These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35473691)

  • 1. Foot-related diabetes complications: care pathways, patient profiles and costs.
    Kurkela O; Nevalainen J; Arffman M; Lahtela J; Forma L
    BMC Health Serv Res; 2022 Apr; 22(1):559. PubMed ID: 35473691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrared Thermography Compared to Standard Care in the Prevention and Care of Diabetic Foot: A Cost Analysis Utilizing Real-World Data and an Expert Panel.
    Kurkela O; Lahtela J; Arffman M; Forma L
    Clinicoecon Outcomes Res; 2023; 15():111-123. PubMed ID: 36855751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Societal costs of diabetes mellitus in Denmark.
    Sortsø C; Green A; Jensen PB; Emneus M
    Diabet Med; 2016 Jul; 33(7):877-85. PubMed ID: 26414087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of foot complications in patients with Type 2 diabetes mellitus on public healthcare: An analysis based on the Korea National Diabetes Program Cohort.
    Park SY; Rhee SY; Chon S; Ahn KJ; Kim SH; Baik SH; Park Y; Nam MS; Lee KW; Woo JT; Chun KH; Kim YS;
    J Diabetes Complications; 2017 Feb; 31(2):375-380. PubMed ID: 27445007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model.
    Crawford F; Chappell FM; Lewsey J; Riley R; Hawkins N; Nicolson D; Heggie R; Smith M; Horne M; Amanna A; Martin A; Gupta S; Gray K; Weller D; Brittenden J; Leese G
    Health Technol Assess; 2020 Nov; 24(62):1-198. PubMed ID: 33236718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare costs of diabetic foot disease in Italy: estimates for event and state costs.
    Seghieri C; Ferrè F; Foresi E; Borghini A
    Eur J Health Econ; 2023 Mar; 24(2):169-177. PubMed ID: 35511310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calculation of the costs of drugs, medical materials, certain medical procedures and social services for patients with diabetic foot syndrome].
    Brunerová L; Andĕl M
    Vnitr Lek; 2003 Jun; 49(6):457-64. PubMed ID: 14503474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of inpatient diabetic foot ulcers in Toronto, Canada.
    Syed MH; Salata K; Hussain MA; Zamzam A; de Mestral C; Wheatcroft M; Harlock J; Awartani D; Aljabri B; Verma A; Razak F; Verma S; Al-Omran M
    Vascular; 2020 Oct; 28(5):520-529. PubMed ID: 32379584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-monitoring induced savings on type 2 diabetes patients' travel and healthcare costs.
    Leminen A; Tykkyläinen M; Laatikainen T
    Int J Med Inform; 2018 Jul; 115():120-127. PubMed ID: 29779714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining an episode of care using claims data. Diabetic foot ulcer.
    Mehta SS; Suzuki S; Glick HA; Schulman KA
    Diabetes Care; 1999 Jul; 22(7):1110-5. PubMed ID: 10388976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital discharges for diabetic foot disease in New Zealand: 1980-1993.
    Payne CB; Scott RS
    Diabetes Res Clin Pract; 1998 Jan; 39(1):69-74. PubMed ID: 9597376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru.
    Cárdenas MK; Mirelman AJ; Galvin CJ; Lazo-Porras M; Pinto M; Miranda JJ; Gilman RH
    BMC Health Serv Res; 2015 Oct; 15():483. PubMed ID: 26503154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital separations indicate increasing need for prevention of diabetic foot complications in central Australia.
    Ewald D; Patel M; Hall G
    Aust J Rural Health; 2001 Dec; 9(6):275-9. PubMed ID: 11998261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.
    Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž
    Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes outpatient care before and after admission for diabetic foot complications.
    Ellis E; Ballance K; Lunt H; Lewis D
    J Wound Care; 2010 Apr; 19(4):150-2. PubMed ID: 20379126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study].
    Lippmann-Grob B; Bierwirth RA; Kron P; Leinhos B; Funke K; Huptas M; Grüneberg M; Weich KW; Münscher C; Potthoff F
    Dtsch Med Wochenschr; 2004 Jan; 129(3):75-81. PubMed ID: 14724780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.
    O'Brien JA; Patrick AR; Caro J
    Clin Ther; 2003 Mar; 25(3):1017-38. PubMed ID: 12852716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical costs of complications resulting from type 2 diabetes in the U.S.
    O'Brien JA; Shomphe LA; Kavanagh PL; Raggio G; Caro JJ
    Diabetes Care; 1998 Jul; 21(7):1122-8. PubMed ID: 9653606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.